Evidence map›Paper›PMID 25383540›Full record

ArticleNature2015

p63(+)Krt5(+) distal airway stem cells are essential for lung regeneration.

Wei Zuo, Ting Zhang, Daniel Zheng'An Wu, Shou Ping Guan, Audrey-Ann Liew, Yusuke Yamamoto, Xia Wang, Siew Joo Lim, Matthew Vincent, Mark Lessard and 3 more

7 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Nature, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 7 registered trials, which are not on this map. Cited by 353 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
353citing papers in PubMed, 2 pooled it
26.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02722642 phase1 / phase2unknown statusnot on this mapstarted 2016, after this paper: background citation

A Single-center, Non-randomized, Before-and-after Self Control Study of Bronchial Basal Cell Transplantation for Bronchiectasis Treatment

TypeinterventionalSponsorRegend TherapeuticsRan2016 to 2020Enrolled20ConditionsBronchiectasisArmsBronchial basal cells
NCT02745184 phase1 / phase2completednot on this mapstarted 2017, after this paper: background citation

Clinical Efficacy and Safety of Autologous Lung Stem Cell Transplantation in Patients With Idiopathic Pulmonary Fibrosis

TypeinterventionalSponsorShanghai East HospitalRan2017 to 2020Enrolled10ConditionsIdiopathic Pulmonary FibrosisArmsLung stem cells
NCT02796781 phase1 / phase2completednot on this mapstarted 2016, after this paper: background citation

Autologous Lung Stem Cell Transplantation in Patients With Interstitial Lung Diseases

TypeinterventionalSponsorShanghai East HospitalRan2016 to 2020Enrolled15ConditionsInterstitial Lung DiseasesArmsLung stem cells
NCT03021681 nacompletednot on this mapstarted 2016, after this paper: background citation

Huai'an First People 's Hospital,Nanjing Medical University

TypeinterventionalSponsorHuai'an No.1 People's HospitalRan2016 to 2021Enrolled18ConditionsCell TransplantationArmsautologous bronchial basal cell transplantation
NCT03188627 phase1 / phase2completednot on this mapstarted 2018, after this paper: background citation

A Single-centered, Non-randomized, Concurrent Control Study on Autologous Bronchial Basal Cell Transplantation for Treatment of Chronic Obstructive Pulmonary Disease (COPD)

TypeinterventionalSponsorRegend TherapeuticsRan2018 to 2019Enrolled24ConditionsChronic Obstructive Pulmonary DiseaseArmsBronchial basal cells
NCT03655795 phase1unknown statusnot on this mapstarted 2018, after this paper: background citation

Autologous Transplantation of Bronchial Basal Cells for Treatment of Chronic Obstructive Pulmonary Disease (COPD)

TypeinterventionalSponsorRuijin HospitalRan2018 to 2021Enrolled20ConditionsCOPDArmsBronchial basal cells
NCT03655808 phase1 / phase2completednot on this mapstarted 2020, after this paper: background citation

Autologous Transplantation of Bronchial Basal Cells for Treatment of Bronchiectasis

TypeinterventionalSponsorRuijin HospitalRan2020 to 2023Enrolled37ConditionsBronchiectasisArmsBronchial basal cells (BBCs), Bronchoscopic airway clearance treatment (B-ACT)
3 · Its place in the literature

Who cites it

353 citing papers in PubMed, 2 syntheses or guidelines pooled it, 550 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Autologous transplantation of P63Cell reports. Medicine · 2024
    Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Separation of Human P63Analytical chemistry · 2026
    Article
  13. Influenza-induced tuft cell expansion alters ILC-mediated inflammation.bioRxiv : the preprint server for biology · 2026
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. RelA Signaling inInternational journal of molecular sciences · 2026
    Article
  19. Article
  20. Article

293 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Wei ZuoGenome Institute of Singapore, A-STAR, 138672 Singapore.
Ting ZhangGenome Institute of Singapore, A-STAR, 138672 Singapore.
Daniel Zheng'An WuGenome Institute of Singapore, A-STAR, 138672 Singapore.
Shou Ping GuanGenome Institute of Singapore, A-STAR, 138672 Singapore.
Audrey-Ann LiewGenome Institute of Singapore, A-STAR, 138672 Singapore.
Yusuke YamamotoThe Jackson Laboratory for Genomic Medicine, Farmington, Connecticut 06032, USA.
Xia WangThe Jackson Laboratory for Genomic Medicine, Farmington, Connecticut 06032, USA.
Siew Joo LimGenome Institute of Singapore, A-STAR, 138672 Singapore.
Matthew VincentAdvanced Cell Technologies, Marlborough, Massachusetts 01752, USA.
Mark LessardThe Jackson Laboratory, Bar Harbor, Maine 04609, USA.
Christopher P CrumDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Wa Xian1] Genome Institute of Singapore, A-STAR, 138672 Singapore [2] The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut 06032, USA [3] Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA [4] Department of Medicine, National University Health System, 119228 Singapore [5] Department of Genetics and Developmental Biology, University of Connecticut Health Center, Farmington, Connecticut 06030, USA.
Frank McKeon1] Genome Institute of Singapore, A-STAR, 138672 Singapore [2] The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut 06032, USA [3] Department of Medicine, National University Health System, 119228 Singapore.
Agency for Science, Technology and Research · SGJackson Laboratory · USAdvanced Cell Technology (United States) · USBrigham and Women's Hospital · USGenome Institute of Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung diseases such as chronic obstructive pulmonary disease and pulmonary fibrosis involve the progressive and inexorable destruction of oxygen exchange surfaces and airways, and have emerged as a leading cause of death worldwide. Mitigating therapies, aside from impractical organ transplantation, remain limited and the possibility of regenerative medicine has lacked empirical support. However, it is clinically known that patients who survive sudden, massive loss of lung tissue from necrotizing pneumonia or acute respiratory distress syndrome often recover full pulmonary function within six months. Correspondingly, we recently demonstrated lung regeneration in mice following H1N1 influenza virus infection, and linked distal airway stem cells expressing Trp63 (p63) and keratin 5, called DASC(p63/Krt5), to this process. Here we show that pre-existing, intrinsically committed DASC(p63/Krt5) undergo a proliferative expansion in response to influenza-induced lung damage, and assemble into nascent alveoli at sites of interstitial lung inflammation. We also show that the selective ablation of DASC(p63/Krt5) in vivo prevents this regeneration, leading to pre-fibrotic lesions and deficient oxygen exchange. Finally, we demonstrate that single DASC(p63/Krt5)-derived pedigrees differentiate to type I and type II pneumocytes as well as bronchiolar secretory cells following transplantation to infected lung and also minimize the structural consequences of endogenous stem cell loss on this process. The ability to propagate these cells in culture while maintaining their intrinsic lineage commitment suggests their potential in stem cell-based therapies for acute and chronic lung diseases.

Indexed as

RegenerationAnimalsBronchiolesCell DifferentiationCell LineageCell ProliferationDogsHumansInfluenza A Virus, H1N1 SubtypeKeratin-5LungMadin Darby Canine Kidney CellsMiceOrthomyxoviridae InfectionsOxygenPedigreeKeratin-5OxygenPhosphoproteinsTrans-ActivatorsTrp63 protein, mouse

Identifiers

PMID25383540
PMCPMC7095488
OpenAlexW2090978493

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

and 1 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.